Investor Overview

There are currently no events to display.

Global - Overview

Aimmune Therapeutics, Inc., is a biopharmaceutical company developing oral treatments for life-threatening food allergies. The company’s Characterized Oral Desensitization ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune’s first investigational, complex biologic product, AR101, is being developed as a treatment to reduce the frequency and severity and ... more >

Recent News

more >

Upcoming Events

more >
There are currently no events to display.

Past Events

Show events starting after a certain date ( i.e. YYYY-MM-DD)
  • Webcast Image Webcast
    Aimmune Therapeutics Conference Call
    February 16, 2017
    5:00 PM EST
  • Webcast Image Webcast
    Aimmune Therapeutics a 35th Annual J.P. Morgan Healthcare Conference
    January 11, 2017
    5:00 PM PST
  • Webcast Image Webcast
    Aimmune Therapeutics at Prescriptions for Success Healthcare Conference
    December 14, 2016
    2:40 PM EST
  • Webcast Image Webcast
    Aimmune Therapeutics Investor Symposium
    December 01, 2016
    8:00 AM EST
  • Webcast Image Webcast
    Aimmune Therapeutics at The 28th Annual Piper Jaffray Healthcare Conference
    November 29, 2016
    1:00 PM EST
  • Webcast Image Webcast
    Aimmune Therapeutics The 25th Annual Credit Suisse Healthcare Conference
    November 07, 2016
    2:00 PM MST
  • Webcast Image Webcast
    Aimmune Therapeutics Conference Call
    November 04, 2016
    8:00 AM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics AR101 Clinical Update Conference Call
    September 20, 2016
    5:00 PM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics Corporate Conference Call
    August 22, 2016
    4:30 PM EDT
  • Webcast Image Webcast
    Aimmune Therapeutics at Wedbush Pacgrow Healthcare Conference
    August 16, 2016
    9:10 AM EDT